PHARMACEUTICAL COMPOSITION COMPRISING CCN5 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING RETINAL DISEASE
Publication
EP4365299A2
Kind: A2
Mar 18, 2026
Applicants
Olives Biotherapeutics Inc.
Inventors
PARK, Woo Jin, YOON, Aeri
IPC Classifications
A61K 38/18 20060101AFI20240704BHEP
A61K 39/395 20060101ALI20240704BHEP
A61K 31/7105 20060101ALI20240704BHEP
A61K 31/7088 20060101ALI20240704BHEP
A61K 35/12 20150101ALI20240704BHEP
A61K 35/28 20150101ALI20240704BHEP
A61K 35/30 20150101ALI20240704BHEP
A61K 35/545 20150101ALI20240704BHEP
A61K 35/76 20150101ALI20240704BHEP
A61P 27/02 20060101ALI20240704BHEP
C07K 16/22 20060101ALI20240704BHEP
C12N 15/86 20060101ALI20240704BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR